No abstract available
Plain language summary
This comparative effectiveness study assesses the numbers needed to treat in targeted trials of agents for newly diagnosed ovarian cancer.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Carcinoma, Ovarian Epithelial
-
Female
-
Humans
-
Ovarian Neoplasms* / drug therapy